NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Hepatitis Weekly


Susan Hasty, Publisher
Table of Contents . . . December 15th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Hepatitis Weekly | Other Publications

Canadian Medical Association Journal - Canada's supervised injection site is cost-effective

Saint Louis University - Treatment for advanced hepatitis C doesn't work, researchers find

World Journal of Gastroenterology - FibroScan vs. liver biopsy in patients with chronic C hepatitis

Acute Hepatitis - Studies from G.G.C. Vanrijckevorsel and co-researchers in the area of acute hepatitis published

Alcoholism - Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis

Alcoholism - New alcoholism study findings have been reported by V.R. Gordeuk and colleagues

Dialysis - Scientists at Erasmus University target dialysis

Hemochromatosis - Research from University of Western Ontario provides new data on hemochromatosis

Hepatitis B Virus - New hepatitis B virus research from N.C. Tan and co-researchers described

Hepatitis B Virus - Researchers from Environmental Protection Agency report recent findings in DNA research

Hepatitis B Virus - Studies from E. Schiff et al have provided new data on hepatitis B virus

Hepatitis C Virus - Research conducted at G.A. Moore and co-researchers has updated our knowledge about hepatitis C virus

Hepatitis C Virus - Research from B.P. Bell and co-researchers in the area of hepatitis C virus published

Hepatitis C Virus - Research from R.J. Fontana and co-researchers in the area of hepatitis C virus described

Hepatitis C Virus - Researchers' work from Kurume University, Medical Department focuses on hepatitis C virus

Hepatitis C Virus - Scientists at Emory University, Emory Vaccine Center detail research in hepatitis C virus

HIV/AIDS - New findings from S.E. Luckhaupt and co-authors describe advances in HIV/AIDS

HIV/AIDS - Reports outline HIV/AIDS study findings from M.I. Gonzaleztome and colleagues

HIV/AIDS - Research in the area of HIV/AIDS reported from University of Frankfurt

HIV/AIDS Co-Infection - Research on HIV/AIDS co-infection published by O.A. Marzuki et al

Life Sciences - Research conducted at H.L. Bonkovsky and co-authors has provided new information about life sciences

Oral Lichen Planus - Data on oral lichen planus published by A. Gotoh and colleagues

Porphyria - Studies by K. Tarwater and co-authors describe new findings in porphyria

Proteinuria - Research from P. Souraty and colleagues provide new insights into proteinuria

Hepatitis B Virus Therapy - New hepatitis B virus therapy study findings have been reported from Medizinische Hochschule Hannover

Hepatitis B Virus Therapy - Reports outline hepatitis B virus therapy study findings from Hospital General Universitario, Department of Biochemistry

Hepatitis C Virus Risk Factors - Findings in hepatitis C virus risk factors reported from Baylor College of Medicine

Hepatitis C Virus Therapy - Scientists at Mie University, Institute of Medical Sciences target hepatitis C virus therapy

Hepatitis C Virus Vaccines - Findings from National Institutes of Health, Department of Transfusion Medicine provide new insights into hepatitis C virus vaccines

Hepatocellular Cancer Risk Factors - Studies from Shanghai Jiao Tong University, Cancer Institute in the area of hepatocellular cancer risk factors described

Immunization - Investigators at Centers for Disease Control and Prevention zero in on immunization

Immunization - Investigators at Institute for Public Health target immunization

Life Sciences - Reports outline life sciences study results from Peking University, National Laboratory of Protein Engineering and Plant Genetic Engineering

Liver Cancer Epidemiology - Studies from Seoul National University, Institute for Health in the area of liver cancer epidemiology published

Steatosis - Study data from Brown University, Research Center update knowledge of steatosis

Alcoholism - Studies from M. Dominguez and co-researchers yield new data on alcoholism

Hepatitis - New findings from World Health Organization in the area of hepatitis described

Hepatitis - Research from G.Y. Minuk and co-authors provides new data about hepatitis

Hepatitis - Researchers' work from Yale University focuses on hepatitis

Liver Fibrosis - Study findings on liver fibrosis are outlined in reports from J. Iredale and colleagues

Ener1, Inc. - Hybrid/Electric Tech Companies Meet in DC as Top Officials Debate 'Detroit Three' Rescue Plans

Hepatitis B Virus - New Television Campaign In Mandarin To Educate Chinese Americans About Chronic Hepatitis B; Innovation in Communication the First of its Kind from Bristol-Myers Squibb

Hepatitis C Virus - ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection

Hepatitis E Virus - Celgard Receives Battery Development Contract from USABC

Vaccines - Sinovac Releases Statement on Healive Vaccine Suspension

Valeant Pharmaceuticals - Valeant Reports Encouraging End of Treatment Results with Taribavirin at Treatment Week 48 in Phase IIb Study



Return to Top of Page

-----------------------
PR Login